119 related articles for article (PubMed ID: 29405993)
1. Molecular approaches identify a cryptic MECOM rearrangement in a child with a rapidly progressive myeloid neoplasm.
Capela de Matos RR; Othman MAK; Ferreira GM; Costa ES; Melo JB; Carreira IM; de Souza MT; Lopes BA; Emerenciano M; Land MGP; Liehr T; Ribeiro RC; Silva MLM
Cancer Genet; 2018 Feb; 221():25-30. PubMed ID: 29405993
[TBL] [Abstract][Full Text] [Related]
2. t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression.
Tang G; Hu S; Wang SA; Xie W; Lin P; Xu J; Toruner G; Zhao M; Gu J; Doty M; Li S; Medeiros LJ; Tang Z
J Mol Diagn; 2019 Mar; 21(2):343-351. PubMed ID: 30576868
[TBL] [Abstract][Full Text] [Related]
3. Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation.
Gao J; Gurbuxani S; Zak T; Kocherginsky M; Ji P; Wehbe F; Chen Q; Chen YH; Lu X; Jennings L; Frankfurt O; Altman J; Sukhanova M
Genes Chromosomes Cancer; 2022 Feb; 61(2):71-80. PubMed ID: 34668265
[TBL] [Abstract][Full Text] [Related]
4. Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.
Ottema S; Mulet-Lazaro R; Beverloo HB; Erpelinck C; van Herk S; van der Helm R; Havermans M; Grob T; Valk PJM; Bindels E; Haferlach T; Haferlach C; Smeenk L; Delwel R
Blood; 2020 Jul; 136(2):224-234. PubMed ID: 32219447
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations.
Tang Z; Tang G; Hu S; Patel KP; Yin CC; Wang W; Lin P; Toruner GA; Ok CY; Gu J; Lu X; Khoury JD; Medeiros LJ
Cancer Genet; 2019 Apr; 233-234():21-31. PubMed ID: 31109591
[TBL] [Abstract][Full Text] [Related]
6. MECOM rearrangement involving the MYC locus: Two additional patients with the rare translocation, t(3;8)(q26.2;q24), and molecular review.
Smith SC; Qdaisat TZS; Althof PA; Dave BJ; Sanmann JN
Leuk Res; 2020 Aug; 95():106387. PubMed ID: 32535247
[TBL] [Abstract][Full Text] [Related]
7. H2AFY is a novel fusion partner of MECOM in acute myeloid leukemia.
Han Q; Lu J; Wang J; Ye J; Jiang X; Chen H; Liu C; Chen L; Lin T; Chen S; Sun M; Gao F
Cancer Genet; 2018 Apr; 222-223():9-12. PubMed ID: 29666008
[TBL] [Abstract][Full Text] [Related]
8. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W
Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
[TBL] [Abstract][Full Text] [Related]
9.
Elsherif M; Hammad M; Hafez H; Yassin D; Ashraf M; Yasser N; Lehmann L; Elhaddad A
Acta Oncol; 2022 Apr; 61(4):516-522. PubMed ID: 35038958
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Genomic Profiles of Korean Patients with
Lee J; Kim SM; Kim S; Yun J; Jeong D; Lee YE; Roh EY; Lee DS
Ann Lab Med; 2022 Sep; 42(5):590-596. PubMed ID: 35470277
[TBL] [Abstract][Full Text] [Related]
11. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
[TBL] [Abstract][Full Text] [Related]
12. Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.
Baldazzi C; Luatti S; Zuffa E; Papayannidis C; Ottaviani E; Marzocchi G; Ameli G; Bardi MA; Bonaldi L; Paolini R; Gurrieri C; Rigolin GM; Cuneo A; Martinelli G; Cavo M; Testoni N
Genes Chromosomes Cancer; 2016 Apr; 55(4):375-88. PubMed ID: 26815134
[TBL] [Abstract][Full Text] [Related]
13. Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies.
Zhao M; Medeiros LJ; Wang W; Tang G; Jung HS; Sfamenos SM; Fang H; Toruner GA; Hu S; Yin CC; Lin P; Gu J; Peng G; You MJ; Khoury JD; Wang SA; Tang Z
Cancer Genet; 2022 Apr; 262-263():23-29. PubMed ID: 34974290
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms.
George TI; Bajel A
Pathology; 2021 Apr; 53(3):312-327. PubMed ID: 33676766
[TBL] [Abstract][Full Text] [Related]
15. Congenital hypoplastic bone marrow failure associated with a de novo partial deletion of the MECOM gene at 3q26.2.
Kjeldsen E; Veigaard C; Aggerholm A; Hasle H
Gene; 2018 May; 656():86-94. PubMed ID: 29496554
[TBL] [Abstract][Full Text] [Related]
16. MECOM: A Very Interesting Gene Involved also in Lymphoid Malignancies.
Liu K; Tirado CA
J Assoc Genet Technol; 2019; 45(3):109-114. PubMed ID: 31554743
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of the rare translocation t(3;10)(q26;q21) in an acute myeloid leukemia patient.
Jancuskova T; Plachy R; Zemankova L; Hardekopf DW; Stika J; Zejskova L; Praulich I; Kreuzer KA; Rothe A; Othman MA; Kosyakova N; Pekova S
Mol Cytogenet; 2014; 7():47. PubMed ID: 25071866
[TBL] [Abstract][Full Text] [Related]
18. Congenital thrombocytopenia in a neonate with an interstitial microdeletion of 3q26.2q26.31.
Bouman A; Knegt L; Gröschel S; Erpelinck C; Sanders M; Delwel R; Kuijpers T; Cobben JM
Am J Med Genet A; 2016 Feb; 170A(2):504-509. PubMed ID: 26554871
[TBL] [Abstract][Full Text] [Related]
19. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation in MECOM affects MPL regulation in vitro and results in thrombocytopenia and bone marrow failure.
Ammeti D; Marzollo A; Gabelli M; Zanchetta ME; Tretti-Parenzan C; Bottega R; Capaci V; Biffi A; Savoia A; Bresolin S; Faleschini M
Br J Haematol; 2023 Dec; 203(5):852-859. PubMed ID: 37610030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
